Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Here, we present protocols to investigate impairment of the neurovascular unit during experimental autoimmune encephalomyelitis in vivo. We specifically address how to determine blood-brain barrier permeability and gelatinase activity involved in leukocyte migration across the glia limitans. 

Abstract

The neurovascular unit (NVU) is composed of microvascular endothelial cells forming the blood-brain barrier (BBB), an endothelial basement membrane with embedded pericytes, and the glia limitans composed by the parenchymal basement membrane and astrocytic end-feed embracing the abluminal aspect of central nervous system (CNS) microvessels. In addition to maintaining CNS homeostasis the NVU controls immune cell trafficking into the CNS. During immunosurveillance of the CNS low numbers of activated lymphocytes can cross the endothelial barrier without causing BBB dysfunction or clinical disease. In contrast, during neuroinflammation such as in multiple sclerosis or its animal model experimental autoimmune encephalomyelitis (EAE) a large number of immune cells can cross the BBB and subsequently the glia limitans eventually reaching the CNS parenchyma leading to clinical disease. Immune cell migration into the CNS parenchyma is thus a two-step process that involves a sequential migration across the endothelial and glial barrier of the NVU employing distinct molecular mechanisms. If following their passage across the endothelial barrier, T cells encounter their cognate antigen on perivascular antigen-presenting cells their local reactivation will initiate subsequent mechanisms leading to the focal activation of gelatinases, which will enable the T cells to cross the glial barrier and enter the CNS parenchyma. Thus, assessing both, BBB permeability and MMP activity in spatial correlation to immune cell accumulation in the CNS during EAE allows to specify loss of integrity of the endothelial and glial barriers of the NVU. We here show how to induce EAE in C57BL/6 mice by active immunization and how to subsequently analyze BBB permeability in vivo using a combination of exogenous fluorescent tracers. We further show, how to visualize and localize gelatinase activity in EAE brains by in situ zymogaphy coupled to immunofluorescent stainings of BBB basement membranes and CD45+ invading immune cells.

Introduction

The central nervous system (CNS) coordinates all body and mental functions in vertebrates, and CNS homeostasis is essential for a proper communication of neurons. CNS homeostasis is warranted by the neurovascular unit (NVU), which protects the CNS from the changing milieu of the blood stream. The NVU is composed of CNS microvascular endothelial cells, which are biochemically unique and establish the blood-brain barrier (BBB) in continuous crosstalk with pericytes, astrocytes, neurons, and extracellular matrix (ECM) components, establishing two distinct basement membranes1. The endothelial basement membrane that ensheathes the abluminal aspect o....

Protocol

All studies were conducted under the guidelines according to the Swiss legislation on the protection of animals and were approved by the Veterinary Office of the Canton of Bern, Switzerland (permission numbers: BE 31/17 and BE 77/18).

1. Housing of C57BL/6 mice in specific pathogen free (SPF) conditions

  1. House mice in individual ventilated cages with a 12/12 h light-dark cycle. Provide food and water ad libidum. To supervise microbiological quality of the mice, the experimental.......

Representative Results

Assessment of the clinical course of EAE in C57BL/6 mice should result in a disease curve as depicted in Figure 2A and changes in the mouse body weight as presented in Figure 2B. C57BL/6 mice immunized with MOGaa35-55 usually start to develop disease symptoms around day 10-12 after active immunization (Figure 1A). Typically, immunized mice show a transient drop of body weight the day after the injection of the emulsion and the first.......

Discussion

Here, we present a protocol to induce and monitor EAE in female C57BL/6 mice. Females are preferentially chosen, and there is a incidence of women : men of 3:1 in MS. To assess the severity of EAE, we made use of a 3-point scoring sheet. EAE severity is generally scored with respect to the severity of motor dysfunctions. Mice with advanced stages of EAE, i.e. exhibiting a score above 2 should be sacrificed to avoid unnecessary suffering of the animals. Thus, it is recommended to score the mice at close intervals e.g. twi.......

Acknowledgements

We gratefully acknowledge Lydia Sorokin, who has shared her original in situ zymography protocol10 with us. 

....

Materials

NameCompanyCatalog NumberComments
AMCA anti-rabbit antibodyJackson ImmunoResearch111-156-045Store at 4 °C; protect from light
Anti-CD45 Antibody (30F11)Pharmingen07-1401Store at 4 °C
Anti-Laminin AntibodyDAKOZ0097Store at 4 °C
Breeding foode.g. PROVIMI KLIBA SA3336
Individually ventilated cages, Blue line Type II or IIIe.g. Tecniplast 1145T, 1285L
BSA fraction VApplichemA1391Store at 4 °C
Cold gelatineSigma-AldrichG 9391
Coplin jar + racke.g. Carl Roth GmbH + Co. KGH554.1; H552.1
Cy3 anti-rat antibodyJackson ImmunoResearch111-156-144Store at 4 °C; protect from light
Cover slips 24 x 40 mm # 1e.g. Thermo Scientific85-0186-00
Dextran Alexa Fluor 488 (10,000 MW)e.g. Molecular probesD22910Store at -20 °C; protect from light
Dextran Texas Red (3000 MW)InvitrogenD3328Store at -20 °C; protect from light
EnzChek Gelatinase/Collagenase Assay Kit Thermo Fisher Scientific; EnzCheckE12055Store at -20 °C; protect form light
Female C57BL/6J mice (8-12 weeks)e.g. Janvier LabsFemales, 8-12 weeks
Freezing box for histology slidese.g. Carl Roth GmbH + Co. KG2285.1
18G x 1½’’ (1.2mm x 40mm) injection needlee.g. BD, BD Microlance 3304622
27G x ¾’’ – Nr. 20 (0.4mm x 19mm) injection needlee.g. BD, BD Microlance 3302200
30G x ½’’ (0.3 mm x 13 mm) injection needlee.g. BD, BD Microlance 3304000
Incomplete Freund’s adjuvant (IFA)e.g. Santa Cruz Biotechnologysc-24648Store at 4°C
Maintenance foode.g. PROVIMI KLIBA SA3436
MOGaa35-55 peptidee.g. GenScriptStore at -80 °C
microscope slides (Superfrost Plus )Thermo ScientificJ1800AMNZ
Mycobacterium tuberculosis H37RAe.g. BD231141Store at 4 °C 
NaCl 0.9 %B. Braun3535789
O.C.T. compound (Tissue-Tek )Sakura4583
Omnican 50 30G x ½’’B. Braun9151125S
ParaformaldehydeMerck30525-89-4
Pertussis toxine.g. List biological laboratories, Inc.180Store at 4 °C
poly(vinyl alcohole) (Mowiol 4-88)Sigma-Aldrich81381
Protease Inhibitor EDTA free (Roche)Sigma-Aldrich4693132001Store at 4 °C
repelling pen e.g. DAKO Pene.g. DAKOS2002
sealing film e.g. Parafilm Me.g Sigma-AldrichP7793
Silica gele.g. Carl Roth GmbH + Co. KG9351.1
Stitch scissorF.S.T15012-12
syringe 1 mle.g. PRIMO62.1002
syringe 10 mle.g. CODAN Medical ApS2022-05
vaporizer system Univentor 400UNO.BV

References

  1. Tietz, S., Engelhardt, B. Brain barriers: Crosstalk between complex tight junctions and adherens junctions. Journal of Cell Biology. 209, 493-506 (2015).
  2. Wu, C., et al.

Explore More Articles

Experimental Autoimmune EncephalomyelitisBlood brain BarrierMatrix MetalloproteinasesImmune Cell InfiltrationNeuroinflammationEAE ScoringMouse ModelMOG PeptideFreund s AdjuvantPertussis Toxin

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved